Advent gives SEP acquisition boost
Speciality European Pharma (SEP) has secured €15 million (£10 million) from Advent Venture Partners.
News
Speciality European Pharma (SEP) has secured €15 million (£10 million) from Advent Venture Partners.
News
News
Partner content
Accounting and Finance Software
Accounting and Finance Software